Literature DB >> 19577533

Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.

Irena Ivnitski-Steele1, Ann R Holmes, Erwin Lamping, Brian C Monk, Richard D Cannon, Larry A Sklar.   

Abstract

Clinically relevant azole resistance in the fungal pathogen Candida albicans is most often associated with the increased expression of plasma membrane efflux pumps, specifically the ATP-binding cassette (ABC) transporters CaCdr1p and CaCdr2p and the major facilitator superfamily (MFS) transporter CaMdr1p. Development of potent pump inhibitors that chemosensitize cells to azoles is a promising approach to overcome antifungal resistance. Here we identify Nile red as a new fluorescent substrate for CaCdr1p, CaCdr2p, and CaMdr1p. Nile red was effluxed efficiently from Saccharomyces cerevisiae cells heterologously expressing these transporters. Enniatin selectively inhibited the efflux of Nile red from S. cerevisiae cells expressing CaCdr1p or CaMdr1p but not from cells expressing CaCdr2p. This indicates that Nile red can be used for the identification of inhibitors specific for particular transporters mediating antifungal resistance in pathogenic yeast.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19577533      PMCID: PMC2739806          DOI: 10.1016/j.ab.2009.07.001

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  36 in total

1.  High throughput flow cytometry.

Authors:  F W Kuckuck; B S Edwards; L A Sklar
Journal:  Cytometry       Date:  2001-05-01

2.  Novel target genes of the yeast regulator Pdr1p: a contribution of the TPO1 gene in resistance to quinidine and other drugs.

Authors:  M A do Valle Matta; J L Jonniaux; E Balzi; A Goffeau; B van den Hazel
Journal:  Gene       Date:  2001-07-11       Impact factor: 3.688

3.  Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.

Authors:  S Perea; J L López-Ribot; W R Kirkpatrick; R K McAtee; R A Santillán; M Martínez; D Calabrese; D Sanglard; T F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

4.  Overexpression of the MDR1 gene is sufficient to confer increased resistance to toxic compounds in Candida albicans.

Authors:  Davina Hiller; Dominique Sanglard; Joachim Morschhäuser
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  High-throughput flow cytometry: validation in microvolume bioassays.

Authors:  Sergio Ramirez; Charity T Aiken; Brett Andrzejewski; Larry A Sklar; Bruce S Edwards
Journal:  Cytometry A       Date:  2003-05       Impact factor: 4.355

6.  Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.

Authors:  Christian Gauthier; Sandra Weber; Anne-Marie Alarco; Omar Alqawi; Roni Daoud; Elias Georges; Martine Raymond
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates.

Authors:  S Wirsching; S Michel; J Morschhäuser
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

Review 8.  Fluorescent labeling of proteins with nile red and 2-methoxy-2,4-diphenyl-3(2H)-furanone: physicochemical basis and application to the rapid staining of sodium dodecyl sulfate polyacrylamide gels and Western blots.

Authors:  J R Daban
Journal:  Electrophoresis       Date:  2001-03       Impact factor: 3.535

9.  Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.

Authors:  K Nakamura; M Niimi; K Niimi; A R Holmes; J E Yates; A Decottignies; B C Monk; A Goffeau; R D Cannon
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 10.  Antifungal drug resistance to azoles and polyenes.

Authors:  Mar Masiá Canuto; Félix Gutiérrez Rodero
Journal:  Lancet Infect Dis       Date:  2002-09       Impact factor: 25.071

View more
  46 in total

1.  A Combination Fluorescence Assay Demonstrates Increased Efflux Pump Activity as a Resistance Mechanism in Azole-Resistant Vaginal Candida albicans Isolates.

Authors:  Somanon Bhattacharya; Jack D Sobel; Theodore C White
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  ATP Binding Cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia.

Authors:  Stuart S Winter; Jerec Ricci; Li Luo; Debbie M Lovato; Hadya M Khawaja; Tasha Serna-Gallegos; Natalie Debassige; Richard S Larson
Journal:  Health (Irvine Calif)       Date:  2013-05

Review 3.  A high throughput flow cytometric assay platform targeting transporter inhibition.

Authors:  George P Tegos; Annette M Evangelisti; J Jacob Strouse; Oleg Ursu; Cristian Bologa; Larry A Sklar
Journal:  Drug Discov Today Technol       Date:  2014-06

4.  Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p.

Authors:  Luiz R Basso; Charles E Gast; Yuxin Mao; Brian Wong
Journal:  Eukaryot Cell       Date:  2010-03-26

5.  Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.

Authors:  Sarah Tsao; Sandra Weber; Christine Cameron; Dominic Nehme; Elaheh Ahmadzadeh; Martine Raymond
Journal:  J Antimicrob Chemother       Date:  2016-07-07       Impact factor: 5.790

Review 6.  Targeting efflux pumps to overcome antifungal drug resistance.

Authors:  Ann R Holmes; Tony S Cardno; J Jacob Strouse; Irena Ivnitski-Steele; Mikhail V Keniya; Kurt Lackovic; Brian C Monk; Larry A Sklar; Richard D Cannon
Journal:  Future Med Chem       Date:  2016-07-27       Impact factor: 3.808

7.  Employing information theoretic measures and mutagenesis to identify residues critical for drug-proton antiport function in Mdr1p of Candida albicans.

Authors:  Khyati Kapoor; Mohd Rehan; Andrew M Lynn; Rajendra Prasad
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

8.  A comparative study of fat storage quantitation in nematode Caenorhabditis elegans using label and label-free methods.

Authors:  Kelvin Yen; Thuc T Le; Ankita Bansal; Sri Devi Narasimhan; Ji-Xin Cheng; Heidi A Tissenbaum
Journal:  PLoS One       Date:  2010-09-16       Impact factor: 3.240

9.  Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.

Authors:  Miwha Chang; Edward Sionov; Ami Khanal Lamichhane; Kyung J Kwon-Chung; Yun C Chang
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

10.  Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.

Authors:  Indresh Kumar Maurya; Chaitanya Kumar Thota; Sachin Dev Verma; Jyotsna Sharma; Manpreet Kaur Rawal; Balaguru Ravikumar; Sobhan Sen; Neeraj Chauhan; Andrew M Lynn; Virander Singh Chauhan; Rajendra Prasad
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.